Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice

被引:850
作者
Clement, AM
Nguyen, MD
Roberts, EA
Garcia, ML
Boillée, S
Rule, M
McMahon, AP
Doucette, W
Siwek, D
Ferrante, RJ
Brown, RH
Julien, JP
Goldstein, LSB
Cleveland, DW
机构
[1] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[5] McGill Univ, Montreal Gen Hosp, Hlth Care Ctr, Res Inst,Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada
[6] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[7] Massachusetts Gen Hosp E, Day Neuromuscular Res Lab, Charlestown, MA 02139 USA
[8] Boston Univ, Sch Med, Bedford VA Med Ctr, Dept Neurol,Geriatr Res Educ & Clin Ctr, Bedford, MA 01730 USA
[9] Boston Univ, Sch Med, Bedford VA Med Ctr, Dept Pathol,Geriatr Res Educ & Clin Ctr, Bedford, MA 01730 USA
[10] Boston Univ, Sch Med, Bedford VA Med Ctr, Dept Psychiat,Geriatr Res Educ & Clin Ctr, Bedford, MA 01730 USA
关键词
D O I
10.1126/science.1086071
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The most common form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease affecting adult motor neurons, is caused by dominant mutations in the ubiquitously expressed Cu-Zn superoxide dismutase (SOD1). In chimeric mice that are mixtures of normal and SOD1 mutant-expressing cells, toxicity to motor neurons is shown to require damage from mutant SOD1 acting within nonneuronal cells. Normal motor neurons in SOD1 mutant chimeras develop aspects of ALS pathology. Most important, nonneuronal cells that do not express mutant SOD1 delay degeneration and significantly extend survival of mutant-expressing motor neurons.
引用
收藏
页码:113 / 117
页数:5
相关论文
共 36 条
[11]   The color of mice: in the light of GFP-variant reporters [J].
Hadjantonakis, AK ;
Nagy, A .
HISTOCHEMISTRY AND CELL BIOLOGY, 2001, 115 (01) :49-58
[12]  
Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO
[13]  
2-#
[14]   Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) [J].
Howland, DS ;
Liu, J ;
She, YJ ;
Goad, B ;
Maragakis, NJ ;
Kim, B ;
Erickson, J ;
Kulik, J ;
DeVito, L ;
Psaltis, G ;
DeGennaro, LJ ;
Cleveland, DW ;
Rothstein, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (03) :1604-1609
[15]  
Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293
[16]   Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis [J].
Johnston, JA ;
Dalton, MJ ;
Gurney, ME ;
Kopito, RR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12571-12576
[17]   Amyotrophic lateral sclerosis: Unfolding the toxicity of the misfolded [J].
Julien, JP .
CELL, 2001, 104 (04) :581-591
[18]  
JULIEN JP, 1990, J PHYSIOLOGY PARIS, V84, P50
[19]  
KAWAMATA T, 1992, AM J PATHOL, V140, P691
[20]   Minocycline slows disease progression in a mouse model of arnyotrophic lateral sclerosis [J].
Kriz, J ;
Nguyen, MD ;
Julien, JP .
NEUROBIOLOGY OF DISEASE, 2002, 10 (03) :268-278